Gambier Gold Corp. (TSX-V: GGAU) Closes Over-Subscribed Flow-Through Private Placement Financing
VANCOUVER, BC / ACCESSWIRE / March 26, 2021 / Gambier Gold Corp. (TSX-V:GGAU) (the “Company”)…
VANCOUVER, BC / ACCESSWIRE / March 26, 2021 / Gambier Gold Corp. (TSX-V:GGAU) (the “Company”)…
TORONTO, ON / ACCESSWIRE / March 26, 2021 / EYEFI Group Technologies Inc. (CSE:EGTI) is…
TORONTO, ON / ACCESSWIRE / March 26, 2021 / Adcore Inc. (the “Company” or “Adcore“)…
VANCOUVER, BC / ACCESSWIRE / March 26, 2021 / Jackpot Digital Inc. (the “Company” or…
Seamless EASY Token transfers now activated between Ethereum & Binance Smart Chain TORTOLA, VIRGIN ISLANDS…
DIDCOT, UK / ACCESSWIRE / March 26, 2021 / TR-1: Standard form for notification of major holdings…
VANCOUVER, BC / ACCESSWIRE / March 26th, 2021 / LeanLife Health Inc. (CSE:LLP; FSE:LL1, OTCQB:LHLNF)…
AmeraMex to file a Form 12b-25 for a 15-calendar day extension CHICO, CA / ACCESSWIRE…
ANN ARBOR, MI / ACCESSWIRE / March 26, 2021 / Minerco, Inc. “The Magic Mushroom…
MOSCOW, RUSSIA / ACCESSWIRE / March 26, 2021 / Mechel PAO (MOEX:MTLR, NYSE:MTL), one of…
JACKSONVILLE, FL / ACCESSWIRE / March 26, 2021 / GEE Group Inc. (NYSE American:JOB) (“GEE”…
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS…
HOLLYWOOD, CA / ACCESSWIRE / March 26, 2021 / Self-driving cars, solar power, Covid testing,…
Trust Stamp Granted Patent for Identity and Trust Verification Tool ATLANTA, GA / ACCESSWIRE /…
The most exciting image post-production tool on the market is back, and this time, it’s…
Novadiscovery announces new clinical simulation collaboration with Takeda Lyon, France – 26 March, 2021 Novadiscovery…
*** Unofficial English translation – For convenience purposes only *** UCB SA/NV – Public Limited…
CARLSBAD, Calif., March 25, 2021 (GLOBE NEWSWIRE) — Design Therapeutics, Inc., a biotechnology company developing…
BETHESDA, Md., March 25, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (“Gain”) today announced the…
IND accepted for VOR33, Vor’s lead eHSC product candidate for treatment of AML Completed initial…